Axel Hoos
Christian-Albrechts-Universität zu Kiel
2 papers in the Anchorcite directory, published between 2010 and 2011, cited 20,001 times in total.
ORCID profileResearch topics
- Cancer Immunotherapy and Biomarkers · 2 papers
- Cutaneous Melanoma Detection and Management · 2 papers
- Immunotherapy and Immune Responses · 1 paper
- Melanoma and MAPK Pathways · 1 paper
Frequent co-authors
- Steven J O'Day · 2 papers
- Caroline Robert · 2 papers
- Célèste Lebbé · 2 papers
- Jedd D. Wolchok · 2 papers
- Jeffrey S. Weber · 2 papers
- Frank Stephen Hodi · 1 paper
- David F. McDermott · 1 paper
- Robert W. Weber · 1 paper
Papers
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine · 2010 · 15,401 citations
BACKGROUND: An improvement in overall survival among patients with metastatic melanoma has been an elusive goal. In this phase 3 study, ipilimumab--which blocks cytotoxic T-lymphocyte-associated antigen 4 to potentiate an antitumor T-cell response--administered with or without a glycoprotein 100 (gp100)…
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic MelanomaNew England Journal of Medicine · 2011 · 4,600 citations
BACKGROUND: Ipilimumab monotherapy (at a dose of 3 mg per kilogram of body weight), as compared with glycoprotein 100, improved overall survival in a phase 3 study involving patients with previously treated metastatic melanoma. We conducted a phase 3 study…
Metadata from OpenAlex (CC0).